Objective 5 and Deliverables of WP5

Α Cdc6 construct [CAG-loxP-eGFP-STOP-loxp-Cdc6-IRES-βGal (CAG-Cdc6)] was injected in zygote pronuclei. Following implantation in pseudopregnant females resulted in generation of the first known CAG-Cdc6 founders. Currently, these founders are undergoing crossings with C57BL/6J mice to obtain the CAG-Cdc6 mouse model. These mice will be crossed with whole body or tissue specific Cre animals to obtain corresponding Cdc6 overexpressing animal models.

Loading...

Molecular Carcinogenesis Group Members

VG New

Prof. Vassilis G. Gorgoulis

Laboratory of Histology-Embryology
Molecular Carcinogenesis Group
Medical School
National and Kapodistrian University of Athens

 

Biomedical Research Foundation of the Academy of Athens

 

Faculty Institute for Cancer Sciences, University of Manchester,
Manchester Academic Health Science Centre, Manchester, UK

Manchester Centre for Cellular Metabolism,
University of Manchester, Manchester Academic Health Science Centre, Manchester

 

EMBO member

 

 

 

Office Tel: 0030 210-7462352
Fax: 0030 210-7462340
E-mail: [email protected]

News

Also see...

Copyright ©2011-2015, Prof. Gorgoulis Powered by AVMap